Patent · US Active

Controlled release carvedilol formulation

US8883207B2 · kind B2 · utility

0Cited by

2References

14Claims

0Family size

Assignees

TSH Biopharm Corporation Ltd. · TW
INNOPHARMAX, INC. · TW

Inventors

Wei Hao · Webster, US
Tsung-Hsin Lin · Taipei, TW
Ta-Chien Lu · Taipei, TW

Key dates

Filing date	Sep 29, 2010
Grant date	Nov 11, 2014
Priority date	—
Expiry date	Oct 17, 2030

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P9/12
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A controlled release carvedilol formulation for less frequent, preferably once daily administration is described. The controlled release formulation comprises a therapeutically effective amount of carvedilol or a pharmaceutically acceptable salt thereof, a matrix forming polymer, a solubility enhancer and a pharmaceutically acceptable carrier. In one embodiment, a controlled release formulation having a therapeutically effective amount of carvedilol is contained in two or more subunits having different release profiles. The controlled release formulation is usable in the treatment and/or prophylaxis of one or more conditions such as cardiovascular disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.